[Federal Register Volume 78, Number 207 (Friday, October 25, 2013)]
[Notices]
[Page 64016]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2013-25081]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Importer of Controlled Substances, Notice of Registration, Akorn, 
Inc.

    By Notice dated June 18, 2013, and published in the Federal 
Register on July 1, 2013, 78 FR 39337, Akorn, Inc., 1222 W. Grand 
Avenue, Decatur, Illinois 62522, made application by renewal to the 
Drug Enforcement Administration (DEA) to be registered as an importer 
of Remifentanil (9739), a basic class of controlled substance listed in 
schedule II.
    The company plans to import Remifentanil in bulk for use in dosage 
form manufacturing.
    No comments or objections have been received. DEA has considered 
the factors in 21 U.S.C. 823(a) and 952(a) and determined that the 
registration of Akorn, Inc., consistent with the public interest and 
with United States obligations under international treaties, 
conventions, or protocols in effect on May 1, 1971. DEA has 
investigated Akorn, Inc., to ensure that the company's registration is 
consistent with the public interest.
    The investigation has included inspection and testing of the 
company's physical security systems, verification of the company's 
compliance with state and local laws, and a review of the company's 
background and history. Therefore, pursuant to 21 U.S.C. 952(a) and 
958(a), and in accordance with 21 CFR 1301.34, the above named company 
is granted registration as an importer of the basic class of controlled 
substance listed.

     Dated: September 27, 2013.
 Joseph T. Rannazzisi,
 Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. 2013-25081 Filed 10-24-13; 8:45 am]
BILLING CODE 4410-09-P